Andexanet Alfa for Urgent Reversal of Apixaban Before Aortic Surgery Requiring Cardiopulmonary Bypass   Abstract Andexanet alfa is a recombinant factor Xa decoy molecule capable of reversing...

The Future of Open Heart Surgery in The Era of Robotic and Minimal Surgical Interventions   Abstract   It has been over two decades since the very first robotic cardiac surgery was performed. Over...

Fibrinogen levels and postoperative chest drain blood loss in low-weight (   Abstract Introduction: Low-weight ( Methods: Prospective cohort study on 77 patients weighing...

The Role of Tolvaptan Administration After Cardiac Surgery: A Meta-Analysis   Objective To evaluate the efficacy and safety of tolvaptan in fluid management after cardiac surgery compared with...

Intraoperative changes in blood lactate levels are associated with worse short-term outcomes after cardiac surgery with cardiopulmonary bypass   Abstract Background: A high perioperative...

Cardiac Biomarkers Predict Long-Term Survival After Cardiac Surgery   Abstract Background Cardiac biomarkers soluble ST-2 (sST-2) and N-terminal prohormone B-type natriuretic peptide (NT-proBNP)...

HFSA/SAEM/ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices   Abstract Mechanical circulatory support is now widely accepted as a...

Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding   Objective Activated recombinant factor VII (rFVIIa)...

What Makes a Team Work, a Specialty Work, and a Society Work: The SCA/STS Adult Cardiac Anesthesia Section of the STS Database for the SCA/STS Database Sub-Committee   No Abstract